Cardiovascular magnetic resonance imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis

Inflammation and Allergy - Drug Targets

Volumn 14, Issue 1, 2015, Pages 29-36

  Mavrogeni, Sophie I ^a   Bratis, Konstantinos ^a   Karabela, Georgia ^b   Spiliotis, George ^b   Van wijk, Kees ^c   Hautemann, David ^c   Reiber, Johan H C ^c   Koutsogeorgopoulou, Loukia ^d   Markousis Mavrogenis, George ^a   Kolovou, Genovefa ^a   Stavropoulos, Efthymios ^b  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b ATHENS NAVAL HOSPITAL   (Greece)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Cardiovascular magnetic resonance; Stress perfusion fibrosis cardiovascular magnetic resonance; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; FINGER ULCER; HEART DISEASE; HEART MUSCLE FIBROSIS; HUMAN; MALE; MYOCARDIAL PERFUSION RESERVE INDEX; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; SCAR; SYSTEMIC SCLEROSIS; T WAVE INVERSION; ASYMPTOMATIC DISEASE; CARDIAC MUSCLE; CARDIOVASCULAR DISEASES; COMPLICATION; CORONARY BLOOD VESSEL; EARLY DIAGNOSIS; FIBROSIS; FOLLOW UP; HEART; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SCINTISCANNING; SCLERODERMA, DIFFUSE;

ADULT; ASYMPTOMATIC DISEASES; CARDIOVASCULAR DISEASES; CORONARY VESSELS; EARLY DIAGNOSIS; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HEART; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; SCLERODERMA, DIFFUSE;

EID: 84953374431     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871528114666150916112551     Document Type: Article

References (46)

1. Allanore, Y.; Meune, C. Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin. Clin. Exp. Rheumatol., 2010, 28(5 Suppl 62), S48-53.
2. Kobayashi, H.; Yokoe, I.; Hirano, M.; Nakamura, T.; Nakajima, Y.; Fontaine, K.R.; Giles, J.T.; Kobayashi, Y. Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J. Rheumatol., 2009, 36(1), 106-112
3. Pieroni, M.; De Santis, M.; Zizzo, G.; Bosello, S.; Smaldone, C.; Campioni, M.; De Luca, G.; Laria, A.; Meduri, A.; Bellocci, F.; Bonomo, L.; Crea, F.; Ferraccioli, G. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin. Arthritis Rheum., 2014, 43(4), 526-535.
4. Stack, J.; McLaughlin, P.; Sinnot, C.; Henry, M.; MacEneaney, P.; Eltahir, A.; Harney, S. Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone. Scand. J. Rheumatol., 2010, 39(4), 349-350.
5. Schicchi, N.; Valeri, G.; Moroncini, G.; Agliata, G.; Salvolini, L.; Gabrielli, A.; Giovagnoni, A. Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance. Radiol. Med., 2014, 119(12), 885-894.
6. Dimitroulas, T.; Mavrogeni, S.; Kitas, G.D. Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis. Nat. Rev. Rheumatol., 2012, 8(4), 203-213
7. Mavrogeni, S.; Bratis, K.; van Wijk, K.; Stavropoulos, E.; Hautemann, D.; Reiber, J.H.; Kolovou, G. Myocardial perfusionfibrosis pattern in systemic sclerosis, assessed by cardiac magnetic resonance. Int. J. Cardiol., 2012, 159(3), e56-58.
8. Ntusi, N.A.; Piechnik, S.K.; Francis, J.M.; Ferreira, V.M.; Rai, A.B.; Matthews, P.M.; Robson, M.D.; Moon, J.; Wordsworth, P.B.; Neubauer, S.; Karamitsos, T.D. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification. J. Cardiovasc. Magn. Reson., 2014, 4, 16-21.
9. Byers, R.; Marshall, D. Pericardial involvement in systemic sclerosis. Ann. Rheum. Dis., 1997, 56(6), 393-394.
10. Dinser, R.; Frerix, M.; Meier, F.M.; Klingel, K.; Rolf, A. Endocardial and myocardial involvement in systemic sclerosis--is there a relevant inflammatory component? Joint Bone Spine., 2013, 80(3), 320-323.
11. Mavrogeni, S.; Spargias, K.; Markussis, V.; Kolovou, G.; Demerouti, E.; Papadopoulou, E.; Stavridis, G.; Kaklamanis, L.; Douskou, M.; Constantoulakis, P.; Cokkinos, D.V. Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy. Inflamm. Allergy Drug Targets, 2009, 8(5), 390-397.
12. Dziadzio, M.; Giovagnoni, A.; Pomponio, G.; Recanatini, A.; della Costanza, O.P.; Manzin, A.; Casagrande, W.; Gabrielli, A. Acute myocarditis associated with adenoviral infection in a patient with scleroderma. Clin. Rheumatol., 2003, 22(6), 487-490.
13. Bulkley, B.H.; Ridolfi, R.L.; Salyer, W.R.; Hutchins, G.M. Myocardial lesions of progressive systemic sclerosis: a cause of cardiac dysfunction. Circulation, 1976, 53, 483-490.
14. James, T.N. De subitaneis mortibus. VIII. Coronary arteries and conduction system in scleroderma heart disease. Circulation, 1974, 50, 844-856.
15. Kahan, A.; Nitenberg, A.; Foult, J.M.; Amor, B.; Menkes, C.J.; Devaux, J.Y.; Blanchet, F.; Perennec, J.; Lutfalla, G.; Roucayrol, J.C. Decreased coronary reserve in primary scleroderma myocardial disease. Arthritis Rheum., 1985, 28, 637-646.
16. Montisci, R.; Vacca, A.; Garau, P.; Colonna, P.; Ruscazio, M.; Passiu, G.; Iliceto, S.; Mathieu, A. Detection of early impairment of coronary flow reserve in patients with systemic sclerosis. Ann Rheum. Dis., 2003, 62, 890-893.
17. Sulli, A.; Ghio, M.; Bezante, G.P.; Deferrari, L.; Craviotto, C.; Sebastiani, V.; Setti, M.; Barsotti, A.; Cutolo, M.; Indiveri, F. Blunted coronary flow reserve in systemic sclerosis. Rheumatology, 2004, 43, 505-509.
18. Steen, V.D.; Follansbee, W.P.; Conte, C.G.; Medsger, T.A. Jr. Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis. Arthritis Rheum., 1996, 39, 677- 681.
19. Nakajima, K.; Kawano, M.; Hasegawa, M.; Taki, J.; Fujimoto, M.; Takehara, K.; Tonami, N. Myocardial damages in systemic sclerosis detected by gated myocardial perfusion SPECT and sympathetic imaging. Circ. J., 2006, 70, 1481-1487.
20. Lee, C.Y.; Chang, S.M.; Hsiao, S.H.; Tseng, J.C.; Lin, S.K.; Liu, C.P. Right heart function in scleroderma: insights from myocardial Doppler tissue imaging. J. Am. Soc. Echocardiography, 2006, 19, 507-514.
21. Friedrich, M.G.; Sechtem, U.; Schulz-Menger, J.; Holmvang, G.; Alakija, P.; Cooper, L.T.; White, J.A.; Abdel-Aty, H.; Gutberlet, M.; Prasad, S.; Aletras, A.; Laissy, J.P.; Paterson, I.; Filipchuk, N.G.; Kumar, A.; Pauschinger, M.; Liu, P. International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J. Am. Coll. Cardiol., 2009, 53(17), 1475-1487.
22. Allanore, Y.; Vignaux, O.; Arnaud, L.; Puéchal, X.; Pavy, S.; Duboc, D.; Legmann, P.; Kahan, A. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathies-related myocarditis evaluated by magnetic resonance imaging. Ann. Rheum. Dis., 2006, 65, 249-252.
23. Nagel, E.; Klein, C.; Paetsch, I.; Hettwer, S.; Schnackenburg, B.; Wegscheider, K.; Fleck, E. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation, 2003, 108, 432-437.
24. Panting, J.R.; Gatehouse, P.D.; Yang, G.Z.;Grothues, F.; Firmin, D.N.; Collins, P.; Pennell, D.J. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N. Engl. J. Med., 2002, 346, 1948-1953.
25. Schwitter, J.; Nanz, D.; Kneifel, S.; Bertschinger, K.; Buchi, M.; Knusel, P.R.; Marincek, B.; Luscher, T.F.; von Schulthess, G.K. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation, 2001, 103, 2230-2235.
26. Bernhardt, P.; Levenson, B.; Albrecht, A.; Engels, T.; Strohm, O. Detection of cardiac small vessel disease by adenosine-stress magnetic resonance. J. Cardiol., 2007, 121, 261-266.
27. Mavrogeni, S.; Bratis, K.; Sfikakis, P.P. Pleuro-pericarditis, vasculitis, subendocardial and nodular biventricular fibrosis. The multiple faces of systemic sclerosis detected by cardiac magnetic resonance in the same patient. Int. J. Cardiol., 2012, 163(2), e26- 27.
28. Vignaux, O.; Allanore, Y.; Meune, C.; Pascal, O.; Duboc, D.; Weber, S.; Legmann, P.; Kahan, A. Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis. Ann. Rheum. Dis., 2005, 64, 1268-1273.
29. Di Cesare, E.; Battisti, S.; Di Sibio, A.; Cipriani, P.; Giacomelli, R.; Liakouli, V.; Ruscitti, P.; Masciocchi, C. Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). Eur. J. Radiol., 2013, 82(6), e268-273.
30. Mavrogeni, S.; Bratis, C.; Manoussakis, M. Coronary artery abnormalities in CREST syndrome revealed by cardiovascular magnetic resonance imaging. Can. J. Cardiol., 2011, 27(3), 390.e5- 7.
31. Tzelepis, G.E.; Kelekis, N.L.; Plastiras, S.C.; Mitseas, P.; Economopoulos, N.; Kampolis, C.; Gialafos, E.J.; Moyssakis, I.; Moutsopoulos, H.M. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum., 2007, 56, 3827-3836.
32. van den Hoogen, F.; Khanna, D.; Fransen, J.; Johnson, S.R.; Baron, M.; Tyndall, A.; Matucci-Cerinic, M.; Naden, R.P.; Medsger, T.A. Jr.; Carreira, P.E.; Riemekasten, G.; Clements, P.J.; Denton, C.P.; Distler, O.; Allanore, Y.; Furst, D.E.; Gabrielli, A.; Mayes, M.D.; van Laar, J.M.; Seibold, J.R.; Czirjak, L.; Steen, V.D.; Inanc, M.; Kowal-Bielecka, O.; Müller-Ladner, U.; Valentini, G.; Veale, D.J.; Vonk, M.C.; Walker, U.A.; Chung, L.; Collier, D.H.; Ellen Csuka, M.; Fessler, B.J.; Guiducci, S.; Herrick, A.; Hsu, V.M.; Jimenez, S.; Kahaleh, B.; Merkel, P.A.; Sierakowski, S.; Silver, R.M.; Simms, R.W.; Varga, J.; Pope, J.E. Classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann. Rheum. Dis., 2013, 72(11), 1747-1755.
33. LeRoy, E.C.; Black, C.; Fleischmajer, R.; Jablonska, S.; Krieg, T.; Medsger, T.A. Jr.; Rowell, N.; Wollheim, F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol., 1988, 15, 202-205.
34. Grothues, F.; Smith, G.C.; Moon, J.C.; Bellenger, N.G.; Collins, P.; Klein, H.U.; Pennell, D.J. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am. J. Cardiol., 2002, 90, 29-34.
35. Grothues, F.; Moon, J.C.; Bellenger, N.G.; Smith, G.S.; Klein, H.U.; Pennell, D.J. Interstudy reproducibility of right ventricular volumes, function and mass with cardiovascular magnetic resonance. Am. Heart J., 2004, 147, 218-223.
36. Maceira, A.M.; Prasad, S.K.; Khan, M.; Pennell, D.J. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson., 2006, 8, 417-426.
37. Greulich, S.; Ferreira, V.M.; Dall'Armellina, E.; Mahrholdt, H. Myocardial Inflammation-Are We There Yet? Curr. Cardiovasc. Imaging Rep., 2015, 8(3), 6.
38. Mavrogeni, S.; Sfikakis, P.P.; Gialafos, E.; Bratis, K.; Karabela, G.; Stavropoulos, E.; Spiliotis, G.; Sfendouraki, E.; Panopoulos, S.; Bournia, V.; Kolovou, G.; Kitas, G.D. Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res (Hoboken)., 2014, 66(1), 104-112.
39. Raman, S.V.; Aneja, A.; Jarjour, W.N. CMR in inflammatory vasculitis. J. Cardiovasc. Magn. Reson., 2012, 14(1), 82.
40. Pieroni, M.; De Santis, M.; Zizzo, G.; Bosello, S.; Smaldone, C.; Campioni, M.; De Luca, G.; Laria, A.; Meduri, A.; Bellocci, F.; Bonomo, L.; Crea, F.; Ferraccioli, G. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin. Arthritis Rheum., 2014, 43(4), 526-535.
41. Wince, W.B.; Kim, R.J. Molecular imaging: T2-weighted CMR of the area at risk--a risky business? Nat. Rev. Cardiol., 2010, 7, 547- 549.
42. Kellman, P.; Aletras, A.H.; Mancini, C.; McVeigh, E.R.; Arai, A.E. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn. Reson. Med., 2007, 57, 891-897.
43. Aletras, A.H.; Kellman, P.; Derbyshire, J.A.; Arai, A.E. ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart. Magn. Reson. Med.,2008, 59, 229-235.
44. Thuny, F.; Lovric, D.; Schnell, F.; Bergerot, C.; Ernande, L.; Cottin, V.; Derumeaux, G.; Croisille, P. Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis. Radiology, 2014, 271(2), 373-380.
45. Rodríguez-Reyna, T.S.; Morelos-Guzman, M.; Hernández-Reyes, P.; Montero-Duarte, K.; Martínez-Reyes, C.; Reyes-Utrera, C.; Vazquez-La Madrid, J.; Morales-Blanhir, J.; Núñez-Álvarez, C.; Cabiedes-Contreras, J. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography. Rheumatology (Oxford)., 2015, 54(4), 647-654.
46. Allanore, Y.; Meune, C.; Vignaux, O.; Weber, S.; Legmann, P.; Kahan, A. Bosentan increases myocardial perfusion and function in systemic sclerosis: a magnetic resonance imaging and Tissue- Doppler echography study. J. Rheumatol., 2006, 33(12), 2464- 2469.